IMMX CIK: 1873835

Immix Biopharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.59
FY22:
−7.41
FY23:
−11.4
FY24:
−14.6
FY25:
−23.9
Change from FY21 to FY25
millions USD
FY21:
0.00
FY22:
–
FY23:
−0.05
FY24:
−1.18
FY25:
−7.21
Change from FY21 to FY25
millions USD
FY21:
18.8
FY22:
3.23
FY23:
15.5
FY24:
15.9
FY25:
107
millions USD
FY21:
17.3
FY22:
−4.21
FY23:
4.07
FY24:
0.17
FY25:
76.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.59
FY22:
–
FY23:
−11.4
FY24:
−15.8
FY25:
−24.7

All amounts in millions USD Data source:SEC EDGAR